J. David Spafford

J. David Spafford is an Associate Professor in the Department of Biology at the University of Waterloo, conducting research on voltage-gated cation channels (sodium, calcium, NALCN) critical for brain and heart function. He holds cross-appointments in Chemistry and Mechanical Engineering and is affiliated with the Centre for Bioengineering and Biotechnology and The Water Institute.

His educational background includes:

• Ph.D. in Biological Science, University of Alberta, Canada (1998)
• B.Sc. in Physiology and Biology, University of Saskatchewan, Canada (1992)

Dr. Spafford's research centers on neurophysiology and ion channel mechanisms, applying molecular/cellular techniques (fluorescence microscopy, tissue culture, PCR) to develop therapeutics for epilepsy, cardiovascular disease, and cancer. His work bridges basic channel biophysics and clinical pharmacology.

Recent publications reveal trends in ion channel structure-function relationships, particularly selectivity filter mechanisms in sodium/calcium channels and T-type channels as epilepsy drug targets. His studies combine electrophysiology and molecular modeling to address channelopathies and permeation anomalies.

Scientific recognition includes:

• Long-Term Fellowship, International Human Frontiers Science Program (2000)
• University Research Award, Vrije Universiteit, Amsterdam (1999)
• Post-Doctoral Fellowship, Alberta Heritage Foundation for Medical Research (1998)
• Graduate Studentship, Alberta Heritage Foundation for Medical Research (1993)
• Graduate Scholarship, Province of Alberta (1992)

He serves on editorial boards for PLoS One and Frontiers in Psychology, and teaches core neuroscience courses including Cellular Neurophysiology and Systems Neuroscience. While grant details are unspecified, his lab drives translational neuropharmacology research.

The Spafford Neurobiology Research Lab employs advanced biophysical methods to investigate channel gating and permeation, collaborating across Waterloo's bioengineering and water research institutes to address neurological and cardiovascular pathologies.